Werewolf Therapeutics, Inc. (HOWL)
0.99
-0.02
(-1.98%)
USD |
NASDAQ |
Dec 10, 10:10
Werewolf Therapeutics Shareholders Equity (Quarterly): 29.61M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| BioMarin Pharmaceutical, Inc. | 6.057B |
| Insmed, Inc. | 945.57M |
| Viking Therapeutics, Inc. | 713.03M |
| ALX Oncology Holdings, Inc. | 44.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 79.63M |
| Total Liabilities (Quarterly) | 50.01M |
| Debt to Equity Ratio | 1.260 |
| Current Ratio | 3.873 |
| Net Debt Paydown Yield | -0.13% |